Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication 2025366197 · 00
| Application Number | 2025366197 |
| Registration Number | 1892852 |
| Status | 00 |
| Mark (native) | The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design. |
| Mark Type | madrid |
| Owner | The Boston Consulting Group, Inc. |
| Filed | 2025-12-18 |
| Registered | 2025-07-21 |
The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design. has a current status of 00.
The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.
Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable software using generative artificial intelligence (AI) to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technological consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials.
| Name (romanised) | The Boston Consulting Group, Inc. |
'The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design.' is a 00 trademark on the Japan Patent Office register, owned by The Boston Consulting Group, Inc.. The application (2025366197) was filed on 18 December 2025 and registered on 21 July 2025.
This mark is recorded under Class 42 (scientific, IT & design services), specifically covering: Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable software using generative artificial intelligence (AI) to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technological consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials.
Japanese trademark 2025366197 for the mark 'The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design.' in Class 42 is recorded on the Japan Patent Office register as owned by The Boston Consulting Group, Inc.. This covers one specific Japanese trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the Japan Patent Office records the status of Japanese trademark 2025366197 for the mark 'The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design.' as 00.
Japanese trademark 2025366197 for the mark 'The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design.' is registered in Class 42 (scientific, IT & design services). The filed specification reads: Class 42: Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable software using generative artificial intelligence (AI) to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; pro…
Japanese trademark 2025366197 for the mark 'The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design.' was filed at the Japan Patent Office on 18 December 2025 and registered on 21 July 2025.
Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-18.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.